NAV is the sum of all its assets less any liabilities, divided by the number of shares outstanding. The closing price is the last price at which the fund traded.
1Gross expense ratio is 1.09% as of the most recent prospectus. The Fund’s investment adviser has contractually agreed to waive its advisory fees and/or assume as its own expense certain expenses otherwise payable by the Fund to the extent necessary to ensure that total annual fund operating expenses do not exceed 0.75% of average daily net assets until March 1, 2027.
2Gross expense ratio is 0.39% as of the most recent prospectus. The Fund’s investment adviser has agreed to waive the management fees so the Fund’s net expense ratio will not exceed 0.19% of AUM, for assets up to $100 million until at least January 28, 2027.
3Gross expense ratio is 0.89% as of the most recent prospectus. The Sponsor has agreed to waive 0.10% of the management fee until at least 4/17/2027.
4Gross expense ratio is 1.12% as of the most recent prospectus. The Fund’s investment adviser has agreed to waive its management fee in an amount equal to the acquired fund fees and expenses related to any investment in Amplify Seymour Cannabis ETF until January 29, 2027.